AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
CCR3 inhibition for ocular neovascularization and macular degeneration - 1476
Technology Benefits
Inventionincludes methods for inhibiting the CCR3 receptor or its ligands CCL11, CCL24,or CCL26 in order to treat or prevent ocular angiogenesis andneovascularization. Compared to the current clinical approaches of neutralizingVEGF-A, CCR3 blockade is more effective and not toxic to mouse retina.
Detailed Technology Description
None
Country/Region
USA
For more information, please click Here
